Patent ID: 9615758
Date: 2017-04-11
CPC Classifications: A61B,A61K

Claim:
1. A method of targeting a region having reactive oxygen species-associated (ROS-associated) cardiac tissue for ablation in a subject, comprising: (a) performing at least one EGM analysis of a plurality of recorded atrial EGMs for a site in the region suspected of having ROS-associated cardiac tissue; (b) determining one or more correlations of at least one AF EGM characteristic to a region having ROS-associated cardiac tissue from the plurality of recorded atrial EGMs for the site; (c) determining a first outcome of executing step (b) and a second outcome of executing step (b) for the site based upon the one or more correlations of at least one AF EGM characteristic to a region having ROS-associated tissue; wherein the first outcome triggers a first decision to avoid ablation of the analysis region and the second outcome triggers a second decision to perform ablation of the analysis region of the site, wherein the one or more correlations of at least one AF EGM characteristic to a region suspected of having ROS-associated cardiac tissue comprises a further correlation of Ca